Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This gene is classified as a pseudogene and is indicated as "pseudogene similar to part of a member of ANKRD26-like family B." It is not known to produce a functional protein product and is not considered a therapeutic target. The gene is annotated in the Ensembl and GeneCards databases as a non-coding sequence with no established biological function or disease relevance. Its naming reflects homology to the ANKRD26-like protein family, but it lacks evidence for protein-coding potential or regulatory roles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of a member of ANKRD26-like family B (ENSG00000237251).